Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-29

Clinical Trial Update: The Study of AZD8529 for Smoking Cessation in Female Smokers [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating AZD8529 for smoking cessation in female smokers. Results have been posted for the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZD8529

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Tobacco Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-11-29